Chiedi
Consulta
Scopri
Calcola
Registrati
Registrati
Accedi
Accedi
Scopri
HER2-positive early breast cancer: Dual HER2 blockade and ADC-based neoadjuvant regimens outperform single-antibody therapy - Notizie Vera Health